<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02023320</url>
  </required_header>
  <id_info>
    <org_study_id>eki-842</org_study_id>
    <nct_id>NCT02023320</nct_id>
  </id_info>
  <brief_title>Effects of Blueberry Dry Powder on Glycemic Status in Subjects With Prediabetes</brief_title>
  <official_title>A Randomized, Double-blind, Parallel Group Study to Evaluate the Effect of Blueberry Dry Powder on Prediabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hiroshima University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Agricultural Producers' Cooperative Corporation Shinpo-en</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hiroshima University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the present study is to evaluate the effect of blueberry dry powder on
      glycemic status (fasting plasma glucose, 2h glucose concentration after the oral glucose
      tolerance test (OGTT), or HbA1c) in subjects with prediabetes.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in fasting plasma glucose from baseline</measure>
    <time_frame>Every 6 weeks (Overall 12 weeks)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in 2h glucose concentration after the oral glucose tolerance test (OGTT) from baseline</measure>
    <time_frame>Weeks 0 and 12</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in HbA1c from baseline</measure>
    <time_frame>Weeks 0 and 12</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in glycoalbumin from baseline</measure>
    <time_frame>Every 6 weeks (Overall 12 weeks)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in fasting insulin from baseline</measure>
    <time_frame>Weeks 0 and 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in homeostasis model assessment-insulin resistance (HOMA-R) from baseline</measure>
    <time_frame>Weeks 0 and 12</time_frame>
    <description>HOMA-R is calculated as fasting insulin (mU/mL) x fasting glucose (mg/dL) / 405</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in serum C-peptide from baseline</measure>
    <time_frame>Weeks 0 and 12</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Prediabetes</condition>
  <arm_group>
    <arm_group_label>Low dose of blueberry dry powder</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.5 g blueberry dry powder, twice a day for 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High dose of blueberry dry powder</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5.0 g blueberry dry powder, twice a day for 12 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Low dose of blueberry dry powder</intervention_name>
    <arm_group_label>Low dose of blueberry dry powder</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>High dose of blueberry dry powder</intervention_name>
    <arm_group_label>High dose of blueberry dry powder</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Fasting plasma glucose 110-125 mg/dL

        Exclusion Criteria:

          -  Taking anti-diabetic drugs

          -  Taking drugs or functional food that may affect blood glucose level

          -  Fruit allergy

          -  Pregnant or nursing a child

          -  Participation in any clinical trial within 90 days of the commencement of the trial

          -  Renal or hepatic dysfunction

          -  Heart disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fumiko Higashikawa, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hiroshima University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hiroshima University</name>
      <address>
        <city>Hiroshima</city>
        <zip>734-8551</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 17, 2013</study_first_submitted>
  <study_first_submitted_qc>December 23, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 30, 2013</study_first_posted>
  <last_update_submitted>August 7, 2014</last_update_submitted>
  <last_update_submitted_qc>August 7, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 11, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hiroshima University</investigator_affiliation>
    <investigator_full_name>Fumiko Higashikawa</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prediabetic State</mesh_term>
    <mesh_term>Glucose Intolerance</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

